Literature DB >> 53480

Letter: Prostaglandins, ulcerative colitis, and sulphasalazine.

S R Gould.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53480     DOI: 10.1016/s0140-6736(75)90414-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  28 in total

1.  Historical origins of current IBD concepts.

Authors:  J B Kirsner
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 2.  Sulfasalazine. Multiplicity of action.

Authors:  T S Gaginella; R E Walsh
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

Review 3.  Inflammatory intermediaries in inflammatory bowel disease.

Authors:  K Lauritsen; L S Laursen; K Bukhave; J Rask-Madsen
Journal:  Int J Colorectal Dis       Date:  1989       Impact factor: 2.571

4.  Plasma and synovial fluid concentrations of sulphasalazine and two of its metabolites in rheumatoid arthritis.

Authors:  M Farr; A Brodrick; P A Bacon
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

5.  Sulphasalazine and experimental stress ulcers.

Authors:  C W Ogle; C H Cho; S Dai
Journal:  Agents Actions       Date:  1985-12

6.  Inter-relationships between inflammatory mediators released from colonic mucosa in ulcerative colitis and their effects on colonic secretion.

Authors:  T D Wardle; L Hall; L A Turnberg
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

7.  Do prostaglandins cause gastrointestinal mucosal injury?

Authors:  M G Northway; D O Castell
Journal:  Dig Dis Sci       Date:  1981-05       Impact factor: 3.199

8.  Studies on changes of colonic mucosal PGE2 levels and tissue localization in experimental colitis.

Authors:  S Yamashita
Journal:  Gastroenterol Jpn       Date:  1993-04

9.  Inhibition of leucocyte motility by drugs used in ulcerative colitis.

Authors:  J M Rhodes; T C Bartholomew; D P Jewell
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

10.  Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.

Authors:  K Lauritsen; J Hansen; P Bytzer; K Bukhave; J Rask-Madsen
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.